Vaginitis for USMLE Step 2

Vaginitis for the USMLE Step 2 Exam
Definition and Classification
  • Definition
    • Vaginitis is an inflammation of the vaginal mucosa, commonly presenting with discharge, pruritus, odor, and/or irritation.
    • Major causes include:
    • Bacterial Vaginosis (BV): Overgrowth of anaerobic bacteria in the vagina.
    • Vulvovaginal Candidiasis (VVC): Fungal infection, primarily by Candida albicans.
    • Trichomoniasis: Sexually transmitted infection caused by Trichomonas vaginalis.
  • Epidemiology
    • Vaginitis is one of the most common gynecologic complaints, with BV and VVC prevalent in reproductive-age women, while trichomoniasis is the most common non-viral STI worldwide.
Pathophysiology
  • Bacterial Vaginosis (BV):
    • Results from a decrease in lactobacilli, which usually produce lactic acid to maintain a low vaginal pH.
    • A shift in vaginal flora promotes overgrowth of anaerobic bacteria like Gardnerella vaginalis, Mycoplasma, Mobiluncus, and Prevotella.
    • BV is associated with sexual activity but is not considered an STI.
  • Vulvovaginal Candidiasis (VVC):
    • Overgrowth of Candida species, primarily C. albicans, due to an imbalance in vaginal flora.
    • Risk factors include antibiotic use, diabetes, immunosuppression, and elevated estrogen levels (e.g., pregnancy, oral contraceptives).
  • Trichomoniasis:
    • Caused by Trichomonas vaginalis, a flagellated protozoan transmitted through sexual contact.
    • Reinfection is common if sexual partners are not treated, and infection may be asymptomatic in many cases.
Clinical Manifestations
  • Bacterial Vaginosis (BV):
    • Thin, homogeneous gray-white discharge with a “fishy” odor, especially noticeable after intercourse.
    • May include mild irritation or itching, but symptoms are often mild or absent.
  • Vulvovaginal Candidiasis (VVC):
    • Thick, white, “cottage cheese” discharge, generally odorless.
    • Associated with intense pruritus, erythema, vulvar swelling, and sometimes dysuria or dyspareunia.
  • Trichomoniasis:
    • Frothy, yellow-green discharge with a foul odor.
    • Often presents with vaginal itching, erythema, and occasionally “strawberry cervix” (cervical petechiae).
Diagnosis
  • Microscopy (Wet Mount):
blue cells in bacterial vaginosis
    • BV: Presence of clue cells (epithelial cells covered with bacteria) and a positive “whiff test” (fishy odor with KOH application).
    • VVC: Budding yeast and pseudohyphae visible with KOH preparation.
    • Trichomoniasis: Motile, flagellated trichomonads observed in a saline wet mount.
  • pH Testing:
    • BV and Trichomoniasis: Vaginal pH is typically >4.5.
    • VVC: Vaginal pH remains normal (≤4.5).
  • Nucleic Acid Amplification Tests (NAATs):
    • Highly sensitive for detecting Trichomonas vaginalis.
    • Affirm VPIII test is also available to detect Gardnerella, Candida, and Trichomonas.
Management
  • Bacterial Vaginosis (BV):
    • First-Line Therapy:
    • Metronidazole 500 mg orally twice daily for 7 days, or metronidazole gel 0.75% intravaginally for 5 days.
    • Clindamycin 2% cream intravaginally for 7 days.
    • Recurrent BV: Maintenance therapy with metronidazole gel twice weekly for 4-6 months may reduce recurrences.
  • Vulvovaginal Candidiasis (VVC):
    • Uncomplicated VVC: Treated with topical azoles (e.g., clotrimazole, miconazole) for 1-7 days or oral fluconazole 150 mg single dose.
    • Complicated VVC: Extended therapy with topical azoles for 7-14 days or fluconazole 150 mg orally every 3 days for 3 doses.
    • Recurrent VVC: Defined as four or more episodes per year; requires induction therapy with fluconazole, followed by weekly fluconazole maintenance for 6 months.
  • Trichomoniasis:
    • First-Line Therapy: Metronidazole 2 g orally in a single dose or 500 mg twice daily for 7 days.
    • Partner Treatment: Essential to prevent reinfection.
    • Test of Cure: Recommended at 3 months due to high reinfection rates in women.
Key Points
  • Vaginitis is commonly caused by BV, VVC, and trichomoniasis, each with distinct symptoms and management.
  • Symptoms:
    • BV: Thin, gray-white discharge with a fishy odor; pH >4.5.
    • VVC: Thick, white “cottage cheese” discharge with intense pruritus; pH ≤4.5.
    • Trichomoniasis: Frothy, yellow-green discharge with foul odor; pH >4.5.
  • Diagnosis:
    • Wet mount microscopy, pH testing, and NAATs are essential diagnostic tools.
  • Treatment:
    • BV: Metronidazole or clindamycin.
    • VVC: Topical azoles or fluconazole for uncomplicated cases; prolonged therapy for complicated or recurrent cases.
    • Trichomoniasis: Metronidazole with partner treatment to avoid reinfection.
  • Complications:
    • BV and trichomoniasis increase the risk for pelvic inflammatory disease (PID), preterm birth, and susceptibility to other STIs.